Artificial intelligence (AI) assists clinicians by analyzing endoscopic video feeds in real time, helping to highlight subtle tissue anomalies and potential lesions that can be difficult to detect during routine screenings. This continuous digital support enhances diagnostic accuracy, standardizes procedure quality, and reduces cognitive workload for medical teams.

Olympus integrates this technology through OLYSENSE™, a cloud-based AI platform that hosts a scalable portfolio of clinical applications. Designed to seamlessly fit into the modern endoscopy suite, it provides real-time decision support during gastrointestinal examinations to assist physicians in making confident, early-stage clinical decisions.

Narrow Band Imaging™ (NBI™) utilizes specific wavelengths of light to enhance the visual contrast of surface vessels and mucosal morphology. Texture and Color Enhancement Imaging™ (TXI™) complements this by optimizing the appearance of lesions through improved texture, brightness, and color. Together, these technologies facilitate the optical biopsy and the precise demarcation of neoplastic tissue.

Learn more about NBI™

The EUS portfolio combines high-performance ultrasound processors with linear and radial echoendoscopes. These systems provide detailed visualization of the gastrointestinal wall layers and adjacent anatomical structures. This enables high precision in EUS-guided Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB) for definitive histological diagnosis.

To ensure patient safety and the longevity of the equipment, Olympus provides a validated reprocessing cycle. This includes automated endoscope reprocessors that adhere to stringent international standards, as well as specialized cleaning chemistry and single-use valves. These solutions minimize cross-contamination risks and optimize the workflow in endoscopy departments with high patient turnover.